Merrion Pharmaceuticals announces liquidation plan
Company could have around €4.5m to distribute to shareholders
The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.
Following the sale of its intellectual property assets to drug giant Novo Nordisk and changes to the licence agreements between the two companies last year, Merrion became an investment company with a focus on the healthcare sector.
In a statement today, however, Merrion said...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply